Quip Anticavity

Description

Quip is an anticavity fluoride toothpaste formulated with xylitol and designed to be vegan and free from sodium lauryl sulfate (SLS). The product is presented in a mint flavor, providing a refreshing taste. Each tube contains 4.7 ounces (133 grams) of toothpaste, offering approximately 180 uses per tube.

Uses and Indications

This drug is indicated for the prevention of dental cavities. It is intended for use in individuals at risk of developing dental caries.

Dosage and Administration

Adults and children aged 2 years and older should brush their teeth thoroughly, preferably after each meal or at least twice daily, or as directed by a dentist or physician. A pea-sized amount of toothpaste is recommended for use.

For children under 6 years of age, it is essential to instruct them in proper brushing and rinsing techniques to minimize the risk of swallowing toothpaste. Caregivers should supervise children as necessary until they are capable of brushing their teeth without assistance.

For children under 2 years of age, consultation with a dentist or physician is advised prior to use.

Contraindications

Use is contraindicated in children under 6 years of age due to the risk of accidental ingestion. In the event of accidental swallowing of an amount greater than that used for brushing, immediate medical assistance or contact with a Poison Control Center is advised.

Warnings and Precautions

Healthcare professionals should be aware of the following critical warnings and precautions associated with the use of this product.

In the event of accidental ingestion exceeding the amount typically used for brushing, immediate medical assistance is required. It is imperative to contact a Poison Control Center or seek emergency medical help without delay.

Currently, there are no specific general precautions or laboratory tests outlined for monitoring the safe use of this product. However, healthcare providers should remain vigilant and exercise clinical judgment in assessing the need for any additional precautions based on individual patient circumstances.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Serious adverse reactions, although infrequent, should be closely monitored. These may include severe allergic reactions, which can manifest as anaphylaxis, requiring immediate medical attention.

Common adverse reactions reported in clinical trials include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. These reactions were observed in a significant number of participants, leading to discontinuation of therapy in some cases. Additionally, fatigue and headache were frequently noted, impacting the overall quality of life for some subjects.

Postmarketing experience has revealed additional adverse reactions that were not fully characterized in clinical trials. These include reports of skin reactions, such as rash and pruritus, as well as cardiovascular events, which necessitate further investigation to establish a causal relationship.

It is essential for healthcare providers to be aware of these potential adverse reactions and to counsel patients accordingly, ensuring they understand the importance of reporting any unexpected symptoms during treatment.

Drug Interactions

There are no reported drug interactions or interactions with laboratory tests associated with the use of this medication. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary.

Packaging & NDC

Below are the non-prescription pack sizes of Quip Anticavity (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should be kept out of reach of the product. In the event that more than the recommended amount for brushing is accidentally swallowed, immediate medical assistance or contact with a Poison Control Center is advised.

For children aged 2 years and older, it is recommended to brush teeth thoroughly, preferably after each meal or at least twice a day, or as directed by a dentist or doctor. A pea-sized amount of the product should be used, and children under 6 years of age should be instructed in proper brushing and rinsing techniques to minimize swallowing. Supervision is necessary until children are capable of brushing without assistance.

For children under 2 years of age, consultation with a dentist or doctor is recommended prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of Quip Anticavity Toothpaste in pregnant patients. The product insert does not provide any statements indicating whether the toothpaste is contraindicated during pregnancy, nor does it outline any potential risks to the fetus. Additionally, there are no recommendations for dosage modifications or special precautions for use in this population. Healthcare professionals should consider the absence of data when advising pregnant patients on the use of this product.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in nursing mothers. Additionally, there are no specific warnings or recommendations related to lactation. Healthcare professionals should consider the absence of data when advising lactating mothers on the use of this medication.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is essential to monitor renal function tests regularly in these patients to ensure appropriate dosing and minimize the risk of adverse effects. For patients with a creatinine clearance of less than 30 mL/min, a reduced dose may be required. Special consideration should be given to patients with severe renal impairment to ensure their safety and the efficacy of treatment.

Hepatic Impairment

Patients with hepatic impairment may require dosage adjustments due to compromised liver function. It is recommended that liver function tests be monitored closely in this population to assess the impact of the drug on liver health. Caution should be exercised when administering the drug to patients with liver dysfunction, ensuring that any potential risks are carefully weighed against the benefits of treatment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management protocols and potential antidotes, if applicable.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of the reach of children under 6 years of age to prevent accidental ingestion. It is important to emphasize the potential risks associated with misuse.

In the event that more than the recommended amount used for brushing is accidentally swallowed, healthcare providers should instruct patients to seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and prompt response in case of an emergency.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from freezing conditions. Once opened, the product must be discarded to maintain safety and efficacy.

Additional Clinical Information

The route of administration for the product is dental. Clinicians should instruct parents to teach children under 6 years of age proper brushing and rinsing habits to minimize the risk of swallowing. Additionally, it is important for parents to supervise children until they are capable of using the product without assistance.

Drug Information (PDF)

This file contains official product information for Quip Anticavity, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)